A Clinical Study of Safety and Efficacy of T3011 Administered Via Intraperitoneal Injection as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal Cancer
Latest Information Update: 16 Jan 2024
At a glance
- Drugs T 3011 (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
Most Recent Events
- 16 Jan 2024 New trial record